172 related articles for article (PubMed ID: 2487555)
1. Allogeneic marrow transplantation: the Seattle experience.
Hansen JA; Anasetti C; Beatty PG; Martin PJ; Thomas ED
Clin Transpl; 1989; ():105-14. PubMed ID: 2487555
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
3. Current status of allogeneic bone marrow transplantation.
Sobocinski KA; Horowitz MM; Rimm AA; Bortin MM
Biomed Pharmacother; 1992; 46(2-3):57-69. PubMed ID: 1421039
[TBL] [Abstract][Full Text] [Related]
4. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic marrow transplantation: the Seattle experience.
Hansen JA; Anasetti C; Martin PJ; Mickelson EM; Petersdorf E; Thomas ED
Clin Transpl; 1993; ():193-209. PubMed ID: 7918153
[TBL] [Abstract][Full Text] [Related]
6. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
[TBL] [Abstract][Full Text] [Related]
7. Current status of bone marrow transplantation.
Bortin MM; Horowitz MM
Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
[TBL] [Abstract][Full Text] [Related]
8. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s.
Bortin MM; Horowitz MM; Gale RP; Barrett AJ; Champlin RE; Dicke KA; Gluckman E; Kolb HJ; Marmont AM; Mrsic M
JAMA; 1992 Aug; 268(5):607-12. PubMed ID: 1321298
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
10. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
[TBL] [Abstract][Full Text] [Related]
11. Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial.
Nimer SD; Giorgi J; Gajewski JL; Ku N; Schiller GJ; Lee K; Territo M; Ho W; Feig S; Selch M
Transplantation; 1994 Jan; 57(1):82-7. PubMed ID: 8291119
[TBL] [Abstract][Full Text] [Related]
12. Treatment of CML with unrelated donor marrow transplant.
McGlave P
Leuk Lymphoma; 1993; 11 Suppl 1():209-11. PubMed ID: 8251898
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
Ash RC; Horowitz MM; Gale RP; van Bekkum DW; Casper JT; Gordon-Smith EC; Henslee PJ; Kolb HJ; Lowenberg B; Masaoka T
Bone Marrow Transplant; 1991 Jun; 7(6):443-52. PubMed ID: 1873591
[TBL] [Abstract][Full Text] [Related]
14. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
Schneider EM; Dörries K
Transplant Proc; 1993 Feb; 25(1 Pt 2):1271-3. PubMed ID: 8382856
[No Abstract] [Full Text] [Related]
15. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
16. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation for chronic myeloid leukaemia using matched unrelated donors.
Goldman JM; Mackinnon S
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():38-9. PubMed ID: 2627622
[TBL] [Abstract][Full Text] [Related]
18. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
[TBL] [Abstract][Full Text] [Related]
19. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients.
Sviland L; Dickinson AM; Carey PJ; Pearson AD; Proctor SJ
Bone Marrow Transplant; 1990 Feb; 5(2):105-9. PubMed ID: 1968774
[TBL] [Abstract][Full Text] [Related]
20. [New therapeutic possibilities for leukemia in adults. Indications and progress measures for allogeneic bone marrow transplantation].
Brinch L; Evensen SA; Albrechtsen D; Egeland T
Tidsskr Nor Laegeforen; 1991 Jan; 111(3):316-9. PubMed ID: 2000611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
